A phase I/II study of docetaxel /S-1 with radiation for esophageal cancer patients

被引：0
|
作者：
Hirai, T. [1 ]
Matsumoto, H. [1 ]
Hirabayashi, Y. [1 ]
Urakami, A. [1 ]
Yamashita, K. [1 ]
Hiratsuka, J. [1 ]
Imajyo, Y. [1 ]
Tsunoda, T. [1 ]
机构：
[1] Kawasaki Med Sch, Kurashiki, Okayama, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15061
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer
    K Yamaguchi
    T Shimamura
    I Hyodo
    W Koizumi
    T Doi
    H Narahara
    Y Komatsu
    T Kato
    S Saitoh
    T Akiya
    M Munakata
    Y Miyata
    Y Maeda
    H Takiuchi
    S Nakano
    T Esaki
    F Kinjo
    Y Sakata
    [J]. British Journal of Cancer, 2006, 94 : 1803 - 1808
  • [2] Final report of Phase I/II study of docetaxel and S-1 for patients with advanced gastric cancer
    Sakata, Y.
    Yamaguchi, K.
    Hyodo, I.
    Koizumi, W.
    Narahara, H.
    Dol, T.
    Komatsu, Y.
    Kato, T.
    Saitoh, S.
    Akiya, T.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 213 - 213
  • [3] Phase I/II Study of S-1 Plus Cisplatin Alternating With S-1 Plus Docetaxel in Patients With Advanced Gastric Cancer
    Hosokawa, Ayumu
    Ando, Takayuki
    Ogawa, Kohei
    Ueda, Akira
    Yoshita, Hiroki
    Mihara, Hiroshi
    Fujinami, Haruka
    Kajiura, Shinya
    Yabushita, Kazuhisa
    Horikawa, Naoki
    Kobayashi, Yuka
    Yoshioka, Akira
    Origasa, Hideki
    Sugiyama, Toshiro
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (10): : 977 - 981
  • [4] Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis
    Fushida, S.
    Kinoshita, J.
    Kaji, M.
    Hirono, Y.
    Goda, F.
    Yagi, Y.
    Oyama, K.
    Sudo, Y.
    Watanabe, Y.
    Fujimura, T.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (05) : 1265 - 1272
  • [5] Phase I/II study of docetaxel (DOC) and S-1 for patients (pts) with advanced gastric cancer (AGC).
    Hyodo, I
    Yamaguchi, K
    Koizumi, W
    Narahara, H
    Kato, T
    Akiya, T
    Sakata, Y
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 323S - 323S
  • [6] Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis
    S. Fushida
    J. Kinoshita
    M. Kaji
    Y. Hirono
    F. Goda
    Y. Yagi
    K. Oyama
    Y. Sudo
    Y. Watanabe
    T. Fujimura
    [J]. Cancer Chemotherapy and Pharmacology, 2013, 71 : 1265 - 1272
  • [7] Phase I/II trial with docetaxel and S-1 for patients with advanced or recurrent gastric cancer
    Zang, Dae Young
    Song, Hun Ho
    Kwon, Jung Hye
    Jung, Joo Young
    Kim, Hyo Jung
    Kim, Jung Han
    Shin, Hyen Chun
    Park, Young lee
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 314 - 314
  • [8] A phase I/II study of S-1 plus cisplatin alternating with S-1 plus docetaxel in patients with advanced gastric cancer (AGC)
    Hosokawa, A.
    Ogawa, K.
    Kajiura, S.
    Tsukioka, Y.
    Kobayashi, T.
    Horikawa, N.
    Kobayashi, Y.
    Yoshioka, A.
    Sumi, S.
    Sugiyama, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [9] Phase I Study of Docetaxel, Cisplatin and S-1 in Patients with Advanced Gastric Cancer
    Hironaka, Shuichi
    Yamazaki, Kentaro
    Taku, Keisei
    Yokota, Tomoya
    Shitara, Kohei
    Kojima, Takashi
    Ueda, Shinya
    Machida, Nozomu
    Muro, Kei
    Boku, Narikazu
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (11) : 1014 - 1020
  • [10] A phase II study of S-1 with concurrent radiotherapy in elderly patients with esophageal cancer
    Ji, Yongling
    Du, Xianghui
    Tian, Ye
    Sheng, Liming
    Cheng, Lei
    Chen, Ying
    Qiu, Guoqing
    Zhou, Xia
    Bao, Wuan
    Zhang, Danhong
    Chen, Ming
    [J]. ONCOTARGET, 2017, 8 (47) : 83022 - 83029
12345